Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2010
09/14/2010US7796241 Egg micro-crack detection systems
09/14/2010US7795495 utility of beta -synuclein and peptides derived therefrom as anti-amyloidogenic agents ; neurodegenerative diseases such as Alzheimer's and Parkinson's diseases; screening for new anti-amyloidogenic agents
09/14/2010US7795420 Short interfering RNA sequences for use in treatment and prevention of diabetes, alzheimer's and cell proliferative disorders
09/14/2010US7795413 Nucleic acids encoding human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
09/14/2010US7795407 Metastatic breast and colon cancer regulated genes
09/14/2010US7795403 Antibodies directed against prothrombin fragment F1+2, the preparation and use thereof
09/14/2010US7795399 Stable therapeutic proteins
09/14/2010US7795398 for preventing oomycete infection of potato and/or tomato; disease resistant plants; Phytophthora infestans
09/14/2010US7795394 Saitohin gene and uses of same
09/14/2010US7795387 detecting the decreased transcription of messenger RNA transcribed from an RDCVF1 or RDCVF2 polypeptide, in the eye of a human, wherein said decreased transcription is diagnostic of such human's suffering from retinal dystrohy
09/14/2010US7795211 Overexpression of protease hepsin; induce immunology response; inoculation with hepsin peptide; monitoring immunotherapy
09/14/2010US7795182 Method for making biochips
09/14/2010US7795042 red-emitting fluorescent rhodamine dyes; photostable; useful as molecular probes; For use in assays involving staining of cells, protein binding, and/or analysis of nucleic acids (hybridization and sequencing)
09/14/2010US7795041 Multi-polymer-coated magnetic nanoclusters
09/14/2010US7795040 a particle that includes a support substrate having one or more fluorescent materials and a peptide substrate coupled to the support substrate via a functional group of the support substrate; for fluorescence detection
09/14/2010US7795039 Electronic device for communication with living cells
09/14/2010US7795038 High-density lipoprotein assay device and method
09/14/2010US7795035 Determination of carbon nanotube concentration in a solution by fluorescence measurement
09/14/2010US7795033 Assaying a sample for the presence of a genotype associated with antidepressant medication, genotype of 5-hydroxytryptamine (serotonin) receptor 2A, glutamine receptor, ionotropic, kainate 4 and /or B-cell leukemia/lymphoma 2
09/14/2010US7795023 Identification of a pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell
09/14/2010US7795018 expresses CD14, CD34, CD45, type I collagen, and HLA-DR; differentiates into osteoblasts, skeletal myoblasts or chondrocytes; obtained by culturing peripheral blood mononuclear cells (PBMCs) in vitro on fibronectin; noninvasive; will not cause rejection at the time of cell transplantation
09/14/2010US7795009 Tripartite reporter agent comprising two epitope binding agents and an oligonucleotide construct for use in quantitation and identification of target molecules
09/14/2010US7795008 An organized, self-assembled monolayer (SAM) on a sensing surface of a sensor device for identifying at least one foreign material from environment; has a piezoelectric crystal element and a sensor
09/14/2010US7795007 Detection of post-translationally modified peptides with liquid crystals
09/14/2010US7795006 Support having selectively bonding substance fixed thereto
09/14/2010US7794975 Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide
09/14/2010US7794967 Using small RNA molecules comprising metal binding region/domain as tool in detection of modulators which treat and prevent cell proliferation disorders
09/14/2010US7794966 A fructosyl amino acid oxidase (FAOD) is added to a sample to remove a non-analyte glycated amine followed by a protease and measuring the redox reaction; requires only two treatment steps; ability of removing an influence of the non-analyte glycated amine is much better; higher measurement accuracy
09/14/2010US7794963 in vivo labeling and identifying recombinantly produced peptides or proteins within an unpermeabilized prokaryotic host cell; comprise at least one tetracysteine tag are labeled in vivo with a biarsenical labeling reagent that binds to the tetracysteine tag and forms a detectable fluorescent complex
09/14/2010US7794962 capable of processing intron-containing eukaryotic genes, and also can carry out post-translational processing steps such as glyclosylation and protein folding
09/14/2010US7794961 Screening assays for agents that alter inhibitor of apoptosis (IAP) protein regulation of caspase activity
09/14/2010US7794960 Predictive biomarkers in cancer therapy
09/14/2010US7794959 bioassay for identifying a compound which blocks or inhibits bitter taste elicited by one or more bitter compounds present in hydrolyzed soy protein by the activation of a human T2R bitter taste receptor ; eating disorders, food sensing, food absorption, obesity, diabetes, Crohn's disease, celiac disease
09/14/2010US7794958 measuring levels of the beta -subunit of fibrinogen; non-invasive while shortening the time to diagnosis, which is critical for alleviating pain and improving fertility outcomes
09/14/2010US7794957 Eukaryotic genes involved in adult lifespan regulation
09/14/2010US7794956 Gab1 involvement in glucose homeostasis regulation by hepatocytes
09/14/2010US7794955 Transfecting a eukaryotic cell with nucleotide sequence, contacting cell with a candidate compound; determining distribution of expressed protein in cell by detecting the distribution of detectable moiety in cell; drug screening for their ability to interact with transmembrane proteins
09/14/2010US7794954 Detection and measurement of thyroid analyte profile
09/14/2010US7794953 Using differential antibody binding to detect lipocalin-type prostaglandin D2 synthase (L-PGDS) in bodily aspirates; diagnosing spinal and/or nervous system trauma
09/14/2010US7794952 Biomarker isolation and use thereof to characterize physiological state
09/14/2010US7794951 SREBP2gc transcription factors and uses thereof
09/14/2010US7794950 Method for the detection of irradiation treatment of foods
09/14/2010US7794949 diagnosing non-inflammatory chronic pelvic pain syndrome in a male subject by detecting Monocyte chemoattractant protein-1 (MCP-1) and Macrophage Inflammatory Proteins (MIP)
09/14/2010US7794948 Biomarkers for alzheimer's disease
09/14/2010US7794947 Affinity capture of peptides by microarray and related methods
09/14/2010US7794946 kits for detecting antibodies with sensitivity to preferential antigens; generate solid support, join antibodies to support, incubate with antigen, detect bound antigen, recover bound antigen
09/14/2010US7794930 Snail, a new marker for tumour invasion and target protein of new antitumoral compounds
09/14/2010US7794929 Detecting a colorectal cancer and/or gastric cancer, detecting selective hybridization of nucleic acid, therapeutic treatment of a cancer, a kit contains oligonucleotide
09/14/2010US7794928 Norovirus detection, methods and compositions therefor
09/14/2010US7794927 Method for identifying agonists or antagonists of the G-protein coupled receptor mas-like 1
09/14/2010US7794926 diagnosing cancer detecting the presence of survivin in urine samples; kits
09/14/2010US7794925 Diagnosis of clinical infection of a wound
09/14/2010US7794799 Process for producing array plate for biomolecules having hydrophilic and hydrophobic regions
09/14/2010US7794735 Pathogen for bacterial poultry disease
09/14/2010US7794725 Isolated peptides derived from human immunodeficiency virus types 1 and 2 containing fusion inhibitory domains
09/14/2010US7794723 treatment or prophylaxis of cancer using proteins or peptides that elicit T cell mediated immunity; vaccination
09/14/2010US7794720 isolating canine animal plasma; selecting a canine animal for a blood group that does not cause plasma transfusion reaction and/or haemolysis and using the plasma for immunization
09/14/2010US7794719 variable regions peptides for immunizing against amyloid plaque formation; biodrug for dementia, Alzheimer's disease, neuropathy, Down's syndrome, Creutzfeld Jacob disease, Parkinson's disease, amyotropic lateral sclerosis; neuroprotectants; hemostatic agent
09/14/2010US7794692 Methods and compositions for detecting amyotrophic lateral sclerosis
09/14/2010US7794662 Osmotic reaction detector for monitoring biological and non-biological reactions
09/14/2010US7794661 Achieving sufficient signal-to-noise ratio in the signal indicating detected fluorescence by irradiating of each biological specimens with excitation light while rotating a substrate disk, where biological specimens are labeled with a fluorescent material and fixed on the substrate disk
09/14/2010US7794660 Fluid content monitor
09/14/2010US7794659 Analyzer of nucleic acids automatically prepares sample, incubates, analyte isolating, ascertaining target analyte and an amount; automated receptacle transporting from one station to the next; automated diagnostic assay; real-time monitoring of amplification; autocleaning receptacles by surfactant
09/14/2010US7794657 Piezoelectric detector comprising immobilized immunoglobulins and which undergoes volumetric change when in contact with target compounds; drug screening
09/14/2010US7794656 Quantitative/qualitative analyzers for solid, semisolid, or liquid biological samples using a lateral flow assay test strip for minimization of sample handling, manipulation upon introducing sample into receiving chamber, mixing with a buffer, and transferring to a test chamber; kits; food, soils
09/14/2010US7794575 Monitoring of gas sensors
09/14/2010US7793410 Method of making a plurality of flow sensors
09/14/2010CA2633573C Inhibition of tau-tau-association
09/14/2010CA2594217C Reservoir sample chain-of-custody
09/14/2010CA2573933C Method to measure dynamic internal calibration true dose response curves
09/14/2010CA2552986C Kinase and phosphatase assay based on fret
09/14/2010CA2480521C Reducing non-specific binding in immunoassays performed on polymeric solid phases
09/14/2010CA2469796C Analytical method for detecting alkaline sphingomyelinase and kit for use in such method
09/14/2010CA2466590C Thin film ethanol sensor and a process for the preparation
09/14/2010CA2452800C Flow control metering system and method for controlling filtration of liquid-based specimens
09/14/2010CA2398748C Immunological assay system and method
09/14/2010CA2373314C Nucleic acid-based detection
09/14/2010CA2370393C Dna sequence, and recombinant production of a gramineae allergen
09/14/2010CA2370123C Polynucleotide probes for detection and quantitation of actinomycetes
09/14/2010CA2364146C Method for processing a nucleic acid sample by oscillating a cartridge, a system and a cartridge for performing such a method
09/14/2010CA2331953C Rapid assay for testing overall oxidative stress
09/14/2010CA2322792C Polypeptides homologous to vegf and bmp1
09/14/2010CA2260291C Antagonists of intestinotrophic glp-2 peptides
09/14/2010CA2257821C Genes from 20q13 amplicon and their uses
09/14/2010CA2251755C Photolabile polymer array synthesis methods
09/14/2010CA2191475C A drug, containing one or more plasma derivatives
09/14/2010CA2146693C Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof
09/13/2010CA2656930A1 Method of ensuring safety of food products
09/12/2010CA2658259A1 Dengue virus-like particle and uses thereof
09/10/2010WO2010102310A2 Systems, methods, and devices having stretchable integrated circuitry for sensing and delivering therapy
09/10/2010WO2010102285A1 Rapid lateral flow glycan-detecting device
09/10/2010WO2010102277A2 Methods of diagnosing and treating prostate cancer characterized by ndrg1-erg fusion
09/10/2010WO2010102215A2 Automated placental measurement
09/10/2010WO2010102195A2 Annexin a11 and associated genes as biomarkers for cancer
09/10/2010WO2010102177A1 Glycodelin monoclonal antibodies and methods for their use in the detection of ovarian cancer
09/10/2010WO2010102162A1 Quantitation of serum cell signaling pathway proteins
09/10/2010WO2010102160A2 Diagnostic method using palb2
09/10/2010WO2010102070A1 Methods of treating hpv-associated cancer with jnk inhibitors
09/10/2010WO2010101947A2 Rapid oligo probes
09/10/2010WO2010101931A2 Detection system and method for high sensitivity fluorescent assays